Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.
Liu, X., Wang, Y., Gutierrez, J.S., Damsker, J.M., Nagaraju, K., Hoffman, E.P., Ortlund, E.A.(2020) Proc Natl Acad Sci U S A 117: 24285-24293
- PubMed: 32917814 
- DOI: 10.1073/pnas.2006890117
- Primary Citation of Related Structures:  
6W9K, 6W9L, 6W9M - PubMed Abstract: 
Duchenne muscular dystrophy is a genetic disorder that shows chronic and progressive damage to skeletal and cardiac muscle leading to premature death. Antiinflammatory corticosteroids targeting the glucocorticoid receptor (GR) are the current standard of care but drive adverse side effects such as deleterious bone loss ...